KOREA UNITED PHARM INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25,350 KRW | +1.40% |
|
+3.89% | -6.11% |
| 2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
| 2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
KOREA UNITED PHARM. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Companyâs products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. It also provides active pharmaceutical ingredients (APIs) and various health food products. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -6.11% | 273M | |
| +21.59% | 44.15B | |
| +23.03% | 23.02B | |
| +18.22% | 15.33B | |
| +12.26% | 13.74B | |
| +52.55% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.66B |
- Stock Market
- Equities
- A033270 Stock
- Funds and ETFs Korea United Pharm Inc.